Kenneth was appointed to finance leadership positions at Pharming Group N.V. in September 2025.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kenneth was appointed to finance leadership positions at Pharming Group N.V. in September 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- Kenneth
-
Gilead Sciences
American company
Coverage
Newest first; wire copies grouped- GlobeNewswirePharming Group appoints Kenneth Lynard as Chief Financial Officer Leiden, the Netherlands, September 2, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today a